AbCellera Biologics Inc. (ABCL)
NASDAQ: ABCL
· Real-Time Price · USD
4.58
0.08 (1.78%)
At close: Aug 15, 2025, 3:59 PM
4.61
0.66%
After-hours: Aug 15, 2025, 07:54 PM EDT
AbCellera Biologics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -45.62M | -34.21M | -51.11M | -36.93M | -40.61M | -47.15M | -28.61M | -30.53M | -40.11M | -29.89M | 26.62M | -6.79M | 168.57M | 59.95M | -21.38M | -2.32M | 117.22M |
Depreciation & Amortization | 5.33M | 13.9M | 33.48M | 38.04M | 6.77M | 9.11M | 7.41M | 7.26M | 7.12M | 15.36M | 6.73M | 6.04M | 4.97M | 4.86M | 4.21M | 4.21M | 3.97M |
Stock-Based Compensation | 14.79M | 15.23M | 17.16M | 17.78M | 17.41M | 16.45M | 15.86M | 16.4M | 15.47M | 13.32M | 11.75M | 12.11M | 12.29M | 9.04M | 7.71M | 8.47M | 5.43M |
Other Working Capital | n/a | 28.39M | -44.14M | 3.08M | -3.53M | 32.87M | 2.44M | 20.08M | -25.05M | -39.39M | -179.51M | 262.2M | -77.03M | 364K | 9.18M | 23.04M | 4.16M |
Other Non-Cash Items | n/a | -17.82M | -22.6M | 64.16M | 56.1M | -1.39M | -1.93M | -795K | -3.63M | 3.13M | 3.6M | 294K | -592K | 2.68M | 1.31M | -228K | -191K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | 1.96M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.25M | -4.02M | 133K | 623K |
Change in Working Capital | n/a | 15.27M | -5.82M | -7.79M | -26.98M | 1.41M | 7.16M | 27.57M | -22.91M | 28.99M | -175.49M | 261.35M | -85.03M | -94.49M | 6.25M | 147.41M | -17.5M |
Operating Cash Flow | -11.55M | -8M | -28.88M | -29.46M | -41.71M | -19.61M | -106K | 19.9M | -44.06M | 30.91M | -126.79M | 273.01M | 100.22M | -16.71M | -5.93M | 157.68M | 109.55M |
Capital Expenditures | -10.64M | -15.63M | -18.52M | -19.8M | -24.14M | -14.43M | -20.89M | -27.2M | -14.98M | -12.33M | -14.51M | -31.32M | -14.49M | -9.43M | -8.57M | -36.8M | -3.64M |
Cash Acquisitions | n/a | n/a | 10.82M | -4.91M | -5.91M | -3.48M | -3.54M | -2.2M | -4.47M | -5.91M | -4.08M | -7.36M | -8.34M | -3.22M | -18.05M | -8.31M | -12.2M |
Purchase of Investments | -164.99M | -152.84M | -178.51M | -174.07M | -259.66M | -284.73M | -215.78M | -170.16M | -395.49M | -93.55M | -541.84M | -82.53M | -63.43M | -29.4M | -257.81M | -13.75M | -12.2M |
Sales Maturities Of Investments | n/a | 182.88M | 206.19M | 232.94M | 306.55M | 268.02M | 220.1M | 160.18M | 262.64M | 92.39M | 272.43M | 88.51M | 57.29M | 18.08M | 9.53M | n/a | n/a |
Other Investing Acitivies | 183.56M | 6.56M | -15.64M | 12.44M | 7.17M | 10.29M | 7.33M | 5M | 2.69M | 2.33M | 6M | 5.5M | 2.6M | 22.81M | 5.29M | -514K | -12.2M |
Investing Cash Flow | 7.93M | 35.7M | 4.28M | 51.52M | 29.91M | -24.32M | -12.79M | -34.39M | -149.61M | -17.06M | -281.99M | -27.2M | -26.37M | -1.15M | -269.63M | -45.63M | -15.84M |
Debt Repayment | n/a | n/a | n/a | 2.34M | n/a | 3.95M | 7M | 148K | n/a | 2.75M | 231K | 234K | 1.94M | n/a | n/a | -2.66M | -1.54M |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.75M | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 5.97M | 5.49M | 3.15M | -180.4K | 2.83M | -185K | -372K | 271K | -948K | -2.41M | -250K | 939K | -5.07M | 1.83M | 898K | -2.42M | n/a |
Financial Cash Flow | 5.97M | 4.14M | 3.15M | 2.61M | 2.83M | 3.77M | 6.63M | 419K | -458K | 349K | -19K | 1.17M | -3.13M | 1.83M | 898K | -5.08M | -1.54M |
Net Cash Flow | 2.94M | 29.68M | -19.38M | 24.74M | -11.35M | -39.1M | -7.33M | -13.27M | -194.34M | 14.56M | -417.35M | 245.78M | 70.51M | -16.55M | -274.88M | 106.78M | 91.68M |
Free Cash Flow | -22.19M | -23.63M | -47.4M | -49.26M | -65.85M | -34.04M | -21M | -7.3M | -59.05M | 18.58M | -141.3M | 241.69M | 85.72M | -26.14M | -14.51M | 120.88M | 105.9M |